CFO of Whitehawk Therapeutics Balances Gains and Liquidity in Strategic March Trades
Whitehawk CFO’s March 2026 insider trades show strategic buying & selling, underscoring confidence in the biotech’s upside while managing liquidity.
3 minutes to read